Stuart Poulton
Corporate Officer/Principal presso KARYOPHARM THERAPEUTICS INC.
Patrimonio netto: 38 926 $ in data 30/04/2024
Profilo
Stuart Poulton is currently the Chief Development Officer & Executive VP at Karyopharm Therapeutics, Inc. Prior to his current position, he worked as the Executive Director-Global Program Management at Amgen, Inc. from 2013 to 2016.
He also held the position of Head-Clinical Operations at Eli Lilly & Co. Additionally, Mr. Poulton served as the Vice President-Clinical Development Operations at AbbVie, Inc. from 2019 to 2022.
He completed his graduate degree at The University of New South Wales and his undergraduate degree at The University of Sydney.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 29/03/2024 | 36 723 ( 0.03% ) | 38 926 $ | 30/04/2024 |
Posizioni attive di Stuart Poulton
| Società | Posizione | Inizio |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 01/02/2022 |
Precedenti posizioni note di Stuart Poulton
| Società | Posizione | Fine |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/01/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2016 |
| ELI LILLY AND COMPANY | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Stuart Poulton
| The University of Sydney | Undergraduate Degree |
| The University of New South Wales | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
- Borsa valori
- Insiders
- Stuart Poulton
